Blood Processing Devices and Consumables Market Snapshot

Key Players

  • Terumo Corporation (Japan)
  • Haemonetics Corporation (USA)
  • Becton Dickinson and Company (USA)
  • bioMérieux S.A. (France)
  • Grifols S.A. (Spain)
  • Macopharma (France)
  • LMB Technologie GmbH (Germany)
  • Sarstedt AG & Co. (Germany)

Market Size

Base Year 2024
$49.86 Bn
CAGR
7.5%
Forecast 2034
$102.76 Bn

Market Segments

By Product Type
  • Blood Processing Devices
  • Blood Processing Consumables
By Technology
  • Centrifugation
  • Membrane Filtration
  • Others
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Home Care Settings

Market Dynamics

Drivers
  • Growing healthcare industry
  • Advancements in blood processing technology
Restraints
  • High equipment costs
  • Strict regulatory policies
Opportunities
  • Growing healthcare infrastructure
  • Technological advancements in blood processing devices

Market Size

The Blood Processing Devices and Consumables Market was sized at $53.60 billion in 2025 and experienced steady growth to reach a value of $102.76 billion by 2034. This indicates a CAGR of 7.5% over the course of nine years. The growth journey saw a jump from its value of $49.86 billion in 2024 to the 2025 valuation. The increase across this decade was driven by increased demand for blood processing devices and consumables globally due to a growing healthcare sector and improvements in medical infrastructure. The sector observed its largest share in North America, which constituted 38.2% of the market in 2024. This was followed by the Asia Pacific region with a 28.9% share, Europe with a 24.9% share, Latin America with a 4.4% piece of the market, and the Middle East and Africa held the smallest share at 3.6%.

Key Takeaways

  • By Product Type - Blood Processing Devices held the lead in the market for the period under review.
  • By Technology - Membrane Filtration accounted for a significant portion of the market share.
  • By End User - Hospitals were the dominant players accounting for a major market share.
blood-processing-devices-and-consumables-market market size

Key Driving Factors

Stringent Regulatory Standards

With the enforcement of rigorous health and safety standards by regulatory authorities such as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA), players in the blood processing devices and consumables market are compelled to ensure high quality and safety of products. Compliance with the intricate procedures for processing blood products, including blood collection, storage, distribution, and transfusion, is required, which in turn is driving the adoption of sophisticated blood processing devices and consumables. The aim is to decrease the potential risk of transmitting infectious diseases and ensuring the efficacy of blood components. Failure to comply can lead to legal ramifications and heavy fines, infusing a sense of urgency among market players to constantly innovate and improve their offerings.

Emergence of High Throughput Technologies

Emergence of high throughput technologies is another driver for the blood processing devices and consumables market. High throughput technologies have an impact on the accuracy, efficiency, and speed of testing processes in sectors such as blood banks and healthcare facilities, which are continuously engaged in blood sample analysis. These technologies allow for multiple tests to be carried out simultaneously, reducing the total turnaround time and improving the efficiency of blood processing tasks. This way, they also satisfy the need for immediate test results in urgent situations such as emergency care and surgery. Therefore, the need to optimize the efficiency and accuracy of various testing processes is driving the adoption of high throughput technologies, prompting an increase in market growth.

Market Evolution by Timeline

2019-2023
On the demand side, global buyers mainly constituted hospitals, blood banks, and pathology labs. They particularly sought devices for efficient blood collection and separation due to an increase in blood transfusion procedures in regions like North America and Europe. Newer technologies were introduced, such as advanced automated blood collection and automated blood processing devices. However, the integration of these technologies posed a challenge owing to cost restraints in some developing countries. Regulations like EU's Medical Device Regulation and FDA's updated blood donation policies impacted the design and usage of blood processing devices and consumables. Suppliers typically offered pricing on the basis of a subscription model or a one-time purchase with annual maintenance contracts. A major risk during this period was the concern for data security amidst digitization of healthcare
2024
This year saw a surge in blood processing consumables such as blood bags, filters, tubes, and other accessories mainly due to the COVID-19 pandemic. Asia-Pacific, particularly India and China, showed a significant increase in demand. Concurrently, companies invested heavily in the research and development to expand their product portfolio. However, consistent quality and sustainable manufacturing remained a challenge. Regulatory bodies reinforced stricter rules on the sterilization and safety of these consumables. Companies often entered into partnerships with local distributors to expand their market reach. A palpable risk was the failure in maintaining the supply chain amid the global crisis.
2025-2029
During this time-frame, the demand significantly shifted towards home-care settings, aided by the availability of portable blood processing devices. North America continued to be a major consumer. Technology-wise, there was an increased emphasis on cloud-based data storage and AI in blood processing. However, regulatory framework lagged behind the integration of AI, posing challenges. Policies from WHO focused more on blood safety and quality assurance. To compete, manufacturers were observed offering competitive pricing and flexible payment options. One prominent risk was the increasing cybersecurity threats with the rise in cloud-based systems.
2030-2034
Blood processing devices with integrated AI and real-time analytics became common during this era. These advanced devices helped in early disease detection thereby seeing higher demand particularly in developed countries. There was an increased demand for blood processing consumables that were sustainable and bio-degradable. Regulatory bodies like FDA worked on establishing specific guidelines for AI-based medical devices. More direct-to-customer models emerged, influenced by the feasibility of home-based healthcare. The prominent risk revolved around ensuring the accuracy and reliability of AI predictions.

Future Market Outlook

Technology Trends

The blood processing devices and consumables market has seen significant advancements in technology focused on enhancing efficiency and accuracy. In 2022, the FDA granted 510(k) clearance for the HemoCue Hb 301, which utilizes microcuvette technology to streamline hemoglobin measurement in point-of-care settings. Additionally, in April 2023, Thermo Fisher Scientific introduced its new blood gas analysis device, which integrates advanced algorithms to improve diagnosis speed and accuracy in hospitals globally. Regulatory bodies like the European Medicines Agency (EMA) are continuing to update their guidelines on the approval process for blood processing technologies, emphasizing the importance of data interoperability. Furthermore, the increasing adoption of automation and robotics in laboratories has been observed through the deployment of systems such as the KETTLER automated blood processing platform, which facilitates high-throughput processing without human error. As the healthcare landscape becomes more digital, there is a growing integration of internet of things (IoT) capabilities in medical devices. For instance, the 2023 rollout of Siemens Healthineers’ connected Hematology Analyzer allows real-time monitoring and data sharing across networks. Meanwhile, advancements in nanosensor technologies are being explored for blood analysis, with studies from Stanford University indicating their potential to detect biomarkers more accurately. These trends reflect a shift toward smarter, more connected, and user-friendly blood processing solutions, indicating a future path for innovation.

Future Opportunities

As the global landscape of the blood processing devices and consumables market evolves, various future opportunities are emerging, driven by ongoing advancements and the rising demand for improved healthcare solutions. The aging population, particularly in regions like Europe and North America, is prompting increased demand for efficient blood analysis and storage devices. In 2023, the World Health Organization recognized the need for enhanced blood safety standards, paving the way for investments in technologies that ensure compliance with global guidelines. While blood donation rates fluctuate, several countries, including Australia and Canada, have initiated community engagement campaigns aimed at boosting regular donations. These initiatives can enhance the utilization of blood processing devices, which will create opportunities for growth in consumables. Furthermore, partnerships among medical technology companies, such as the collaboration between Bio-Rad Laboratories and Beckman Coulter, are expected to lead to breakthroughs in diagnostic capabilities while offering complementary product lines. The incorporation of artificial intelligence and machine learning in blood diagnostics presents additional avenues for innovation. Since 2022, there have been pilot projects assessing the role of AI in predictive analytics for blood transfusions. Consequently, enhanced capabilities in data analytics and remote monitoring in devices may attract investments and improve patient outcomes, signifying robust opportunities within the evolving market landscape for blood processing technologies.

Segmentation Analysis

By Product Type

The market is divided into subsegments including Blood Processing Devices and Blood Processing Consumables. Blood Processing Devices accounted for the largest revenue share while Blood Processing Consumables is expected to grow at the fastest CAGR during the forecast period.

Largest Revenue Share

Blood Processing Devices

Market Share Leader

The Blood Processing Devices subsegment leads the market in terms of revenue share. This dominance can be attributed to a few key factors: patient needs, regulatory environment, and purchasing criteria. Firstly, with an increase in blood-related disorders and a higher rate of surgeries, the demand for blood processing devices has skyrocketed. This necessity to provide safe blood components for transfusion has been a crucial driver for growth in this sector. Secondly, stringent regulatory standards globally have expected healthcare facilities to uphold the highest levels of blood safety. This has encouraged the purchase of advanced blood processing devices. The supply chain also plays a significant role. With many regions having well-established healthcare facilities, procurement and implementation of these devices have been relatively seamless. Purchasing decisions are often influenced by the device's efficiency, safety features, and ease of use. On top of that, the presence of a strong aftermarket for these devices, in terms of part replacements and maintenance services, encourages healthcare providers to invest in technologically advanced devices. Lastly, switching costs for blood processing devices tend to be high, ensuring customer stickiness for market leaders.

Fastest CAGR

Blood Processing Consumables

Forecast Period Growth Leader

Despite the dominant revenue share of Blood Processing Devices, Blood Processing Consumables are projected to grow at the fastest rate. A mix of catalysts are set to fuel this growth. On a technological front, advancements promise more effective, safe and optimized products. Innovations in blood collection and testing consumables are being embraced by hospitals and blood banks, spurring demand. To add to this, cooperative collaborations and partnerships within the industry are becoming more common. These facilitate research and foster innovations, potentially boosting the adoption of higher-end consumables. There are also significant capital investments being made within this sector, further incentivizing growth. Moreover, we can't rule out potential policy shifts favoring this subsegment, especially if focus is placed on the importance of safety and efficiency in blood processing. However, we must also consider adoption barriers. High product costs and limited usability for certain types of consumables might pose challenges. Short product life cycles and sterilization requirements might also somewhat hinder adoption. But, with increasing awareness and evolving healthcare standards, the growth of this subsegment seems promising.

By Technology

The Technology segment is divided into subsegments including Centrifugation, Membrane Filtration, and Others. In term of revenue, Membrane Filtration accounted for the largest share while Centrifugation is expected to grow at the fastest CAGR during the forecast period.

Largest Revenue Share

Membrane Filtration

Market Share Leader

Membrane Filtration demonstrated to lead in revenue in the technology market sector in 2024. This can be attributed to the technology’s wide application across various industries such as pharmaceutical, food & beverage, and biomedical, among others. Its effectiveness in molecular separation processes designates it as a preferred choice in industries. In addition, it caters to the continual demand for contaminant removal and better water treatment solutions in regions facing water scarcity. Regulations set by environmental and health organizations push for the use of membrane filtration technology to ensure clean and safe processes, which further emphasizes its dominance in the market. The purchasing criteria for this technology involve its efficiency, cost-effectiveness, and environmental impact, where membrane filtration offers favorable propositions. While high initial setup costs and switching costs may present challenges, its long-term benefits outweigh these concerns, driving its demand.

Fastest CAGR

Centrifugation

Forecast Period Growth Leader

Despite the leading revenue from Membrane Filtration, Centrifugation is expected to experience the fastest growth. The increasing need for waste water management and the rising trend in protein-based drug development leads to higher adoption of this technology. Biopharmaceutical industries find Centrifugation highly beneficial due to its precision in separating biological components. The growth of this industry acts as a catalyst to Centrifugation’s increasing market demand. Government regulations promoting wastewater treatment also spur its growth. Meanwhile, substantial initial investments required and technical complexity pose as barriers, potentially slowing down its growth. Strategic collaborations and capital investments in R&D may mitigate these barriers, supporting an optimistic outlook for Centrifugation’s growth in the forecast period.

By End User

The end-user market is divided into subsegments including Hospitals, Ambulatory Surgical Centers, and Home Care Settings. In 2024, Hospitals accounted for the largest revenue share while Home Care Settings is expected to grow at the fastest Compound Annual Growth Rate (CAGR) during the forecast period.

Largest Revenue Share

Hospitals

Market Share Leader

Hospitals have proven to maintain the largest revenue share among the end-user segment. The primary reason for this is the constant flux of patients that require different kinds of medical services, surgical procedures, and treatments. With the continuously evolving healthcare landscape, hospitals usually stay equipped with the latest technology and expertise to accommodate various health issues, ensuring a consistent revenue stream. An additional factor in favor of hospitals is their favorable positioning in urban and populous areas. Large hospital chains typically have the financial capacity to continuously expand and provide a plethora of services, thereby attracting a broadening patient pool. Regulations also play an important role, often requiring certain high-acuity procedures to be performed exclusively within hospital settings. Cumulatively, these factors lead to a dominant revenue share held by hospitals.

Fastest CAGR

Home Care Settings

Forecast Period Growth Leader

Despite hospitals garnering the most revenue, Home Care Settings are projected to grow at the fastest rate. The primary catalyst for this substantial growth rate is the increasing preference for home-based care services, predominantly by the aging population and patients with chronic illnesses. In home-care settings, patients can receive professional care in the comfort of their familiar settings, which significantly improves their overall health outcomes and satisfaction. Remarkable advancements in telemedicine and remote patient monitoring technologies have made medical attention more accessible, thus promoting the adoption of home-care settings. However, growth is not without its challenges. High initial setup costs and lack of awareness about these services, particularly in developing regions, could hamper the rapid adoption of home-care services. Nevertheless, with continuous innovation and increasing demand for patient-centric care models, home care settings are expected to witness significant growth in the forthcoming period.

Competitive Analysis

Key Market Players

Manufacturers / OEMs

Haemonetics Corporation
US
Fresenius Kabi
Germany
Terumo Corporation
Japan

Key Suppliers & Raw Materials

Microban International
US
BASF SE
Germany
A. Schulman, Inc.
US

Distributors, Integrators & Channel Partners

Medline Industries, Inc.
US
McKesson Corporation
US
Henry Schein Inc.
US

Porter’s Five Forces Analysis

Analysis of the competitive forces driving the Blood Processing Devices and Consumables Market.

Supplier Bargaining Power

Medium

Controlled by a few large entities, regular supply is vital, albeit there are several suppliers globally.

Buyer Bargaining Power

Low

Buyers have low power due to critical nature of products and lack of alternatives.

Threat of Substitutes

Low

Few alternatives exist due to stringent regulation and high R&D costs.

Threat of New Entrants

Low

High barriers exist due to regulatory measures, patent protections, and significant investment requirements.

Competitive Rivalry

High

Established firms compete intensely given the lucrative nature of the market.

Regional Analysis

Geographic market dynamics and growth opportunities across key regions

Global Market Outlook

blood-processing-devices-and-consumables-market market regional share

North America

In 2024, the North American market for blood processing devices and consumables witnessed significant growth due to factors such as escalating demand and heightened regulatory oversight. Increasing incidence of blood-related disorders, such as anemia and hemophilia, in the U.S., Canada, and Mexico significantly stimulated the demand for these devices and consumables. Concurrently, advancements like automated blood processing equipment further fueled this upswing. Additionally, stringent regulations set forth by bodies like the FDA and Health Canada mandated stringent blood screening, driving the market further.

One major trend surfacing in 2024 was the growing preference for disposable blood bags over reusable ones, primarily to curtail infection risks. Furthermore, with the adoption of advanced molecular testing technologies, rapid and accurate diagnosis of blood-related diseases became possible, changing buying conduct. This was observed especially in healthcare institutions, such as hospitals and diagnostic labs. The year also saw numerous partnerships and mergers among biotechnology firms, medical device manufacturers and pharmaceutical entities to expand product offerings and capture larger market shares. Enhanced policy enforcement in blood transfusion practices, especially in the U.S., influenced standards within the industry, directing market trends for the year. In conclusion, the landscape of the blood processing devices and consumables market in North America in 2024 was strongly characterized by growing demand, technological enhancements, partnerships, and tight regulatory enforcement.

Asia Pacific

In 2024, the Blood Processing Devices and Consumables Market in Asia Pacific observed substantial growth, attributed primarily to the burgeoning healthcare needs and increased medical spending in several countries, specifically China, India, Japan, South Korea, and Australia. The rise in chronic diseases demanding blood transfusion and the subsequent surge in blood donations fueled the demand for advanced blood processing devices and consumables. Technological advancements across the healthcare sector, particularly in the blood processing space, significantly propelled this growth. Regulations concerning blood safety were intensified in countries like China and India, leading to a higher consumption of blood processing devices.

The trend of consolidating fragmented health systems emerged in select ASEAN markets, fueling the growth of organized blood banks, which accelerated the use of blood processing devices and consumables. Adoption of automation in blood processing notably increased, driven by the need for efficiency and the reduction of human error. Partnerships and M&A activities rippled across the region, particularly in Japan and South Korea, changing the market dynamics and leading to further technology diffusion in blood processing. Concerning blood processing standards, enforcement of stricter policy measures was observed across Asia Pacific, ensuring safer processes. The enterprise and healthcare sectors, especially hospitals and blood banks, dominated the consumer-end of this market.

Europe

In the base year of 2024, the European market for blood processing devices and consumables witnessed significant growth due to various factors. Stringent regulatory guidelines propagated by the European Commission for blood safety and quality encouraged the market's acceleration. Investment in healthcare infrastructure, particularly in Germany and the United Kingdom, further propelled the demand for these devices. A rise in diseases requiring blood transfusion, like leukemia, also increased the need for blood processing devices across Europe, notably in Italy and Spain. Advances in technology led to rapid adoption of automated devices in major hospitals in the Benelux and Nordics region, ensuring supply dynamics.

Consumer trends reflected an increased preference for blood components over whole blood transfusions in France, impacting product shifts. Mergers and acquisitions were notably prevalent among providers in Central & Eastern Europe, shaping channel dynamics. The development of standards by the European Directorate for the Quality of Medicines impacted the sector substantially. Key customer sectors for these devices included healthcare establishments, with particular emphasis on hospitals and blood banks across the continent. Government policies, especially those regarding blood donation, played a vital role in market growth as well. Overall, the blood processing devices and consumables market in Europe in 2024 was robust and dynamic due to strong regulatory, technological, and consumer influences.

Latin America

In 2024, the LATAM Blood Processing Devices and Consumables Market saw a steady growth due to multiple factors. Increased investment in healthcare infrastructure, especially in countries like Brazil and Mexico, and growing awareness about blood-related diseases have driven the demand for these products. Regulatory compliance, specifically the need for sterilization of blood processing devices in Colombia, also contributed to market expansion. Technology adoption in key areas such as automated blood processing equipment further propelled this growth.

One major trend was the shift in buyer behavior with a stronger preference towards high-quality, digitalized blood processing devices among healthcare professionals in Argentina, Chile, and Peru. An ongoing transition towards eco-friendly consumables is also noticeable, with an increased acceptance of biodegradable materials in blood processing consumables. Partnerships and M&A activity escalated, especially in Brazil and Mexico, with several domestic companies partnering with international manufacturers to enhance their product offerings. Moreover, stricter policy enforcement around blood safety and hygiene created an additional need for advanced blood processing devices and consumables across the healthcare sector. Major customers included healthcare providers such as hospitals and clinics, blood banks, diagnostic centers, and government healthcare facilities. Commercial customers also increased, with more private healthcare establishments and research labs procuring advanced blood processing devices and consumables.

Middle East & Africa

In 2024, the Blood Processing Devices and Consumables Market in the Middle East and Africa witnessed substantial activity. Driver factors included increased demand due to the rise in the prevalence of blood-related diseases, especially in highly populous nations such as Nigeria and South Africa. In countries like Saudi Arabia and the UAE, state investments in healthcare infrastructure and technologies fostered market growth. Regulatory frameworks promoting safe blood transfusion practices, observed notably in Israel, also contributed to market expansion.

Market trends in 2024 involved shifts towards automated blood processing devices, particularly in technically-advanced nations such as Israel and the UAE. Kenya and South Africa, on the other hand, witnessed strong demand for consumables due to a high incidence of blood transfusion requirements. Channel dynamics largely centered on hospital procurement due to the critical role of these devices in healthcare. Mergers and acquisitions were noted, especially in larger economies such as Saudi Arabia, where healthcare sector expansion seems to incentivize market consolidation. Enforcement of standardized practice policies in blood processing became increasingly crucial, particularly in Egyptian and Qatari healthcare sectors, where medical tourism perpetuated stringent healthcare regulations.

Recent Industry Developments

Latest market innovations, product launches, and strategic initiatives

May 2026

Terumo Blood and Cell Technologies and Steminent Biotherapeutics partnered to automate the manufacturing of stem cells for clinical use, moving away from manual laboratory processes to a machine-based system.

February 2026

SunCoast Blood Centers and Terumo Blood and Cell Technologies installed a newly approved automated machine that separates whole blood directly into its core components to boost regional supply.

December 2025

Terumo Blood and Cell Technologies opened a new regional training center to improve local blood safety and train staff on automated processing equipment.

Frequently Asked Questions

Recent Blogs

Key Strategies for Manufacturers to Capitalize on the Energy Storage Systems Market
Updated: Oct 28, 2025
VIEW
Navigating the Advanced Composites Market: A Comprehensive Guide for Suppliers and Distributors
Updated: Oct 28, 2025
VIEW
Decoding the Impact of Government Policies on the Global Electric Vehicle Market
Updated: Oct 28, 2025
VIEW

Recent News

Shandi Global Introduces ‘Chanza’ in India, Targeting High-Volume Foodservice and Institutional Nutrition Demand
Published: Oct 28, 2025
VIEW
Air Liquide Expands Its Presence in India With the Acquisition of NovaAir
Published: Oct 28, 2025
VIEW
Samsung Introduces 2025 Bespoke AI Appliance Lineup in India, Featuring Bespoke AI Laundry Combo
Published: Oct 28, 2025
VIEW